Managed Health Care

Recently, CVS Caremark Corporation (CVS) decided to acquire Universal American's (UAM) Medicare Part D business for $1.25 billion, catering to about 1.9 million Prescription Drug Plan (PDP) members. Subsequent to this acquisition, CVS Caremark's Medicare Part D program will increase manifold as...

Recently, CVS Caremark Corporation (CVS) decided to acquire Universal American's (UAM) Medicare Part D business for $1.25 billion, catering to about 1.9 million Prescription Drug Plan (PDP) members. Subsequent to this acquisition, CVS Caremark's Medicare Part D program will increase manifold as...

Investors mostly stayed away from the Street on Friday, being New Year's Eve and markets closed largely mixed. This was also one of the lightest volume trade days of the year. Though, apart from the Dow, certain benchmarks shed a few points on the closing day, the markets posted an optimistic...

Citi Investment Research has a Buy rating and is raising its price target on Universal American (NYSE: UAM) to $22 from $19. In the research report, Citi writes, "After CVS pays $13 / share for the PDP segment, the market is valuing the remaining Universal business at around $7.45 per share. As...

CVS Caremark (NYSE: CVS) today announced it has entered into an agreement to acquire the Medicare Part D business of Universal American (NYSE: UAM) for approximately $1.25 billion.

As a part of its annual review, the rating agency A.M.Best, yesterday disclosed its findings on UnitedHealth Group Inc. (UNH) and its subsidiaries. Details of the findings are as follows : A.M.Best reaffirmed the financial strength ratings (FSR) of A (Excellent) and issuer credit ratings (ICR...

As a part of its annual review, the rating agency A.M.Best, yesterday disclosed its findings on UnitedHealth Group Inc. (UNH) and its subsidiaries. Details of the findings are as follows : A.M.Best reaffirmed the financial strength ratings (FSR) of A (Excellent) and issuer credit ratings (ICR...

With the closure of the acquisition of Concentra, Inc., Humana Inc. (HUM) has raised its earnings per share guidance for fiscal 2011. Humana now expects its earnings per share in the range of $5.45 - $5.65, up from the previous outlook of $5.35 - $5.55. Humana completed its acquisition of...

With the closure of the acquisition of Concentra, Inc., Humana Inc. (HUM) has raised its earnings per share guidance for fiscal 2011. Humana now expects its earnings per share in the range of $5.45 - $5.65, up from the previous outlook of $5.35 - $5.55. Humana completed its acquisition of...

In an effort to mould the legislation in its favor, health insurer UnitedHealth Group (UNH) has been reported to have spent $550,000 during the three months from July to September 2010. This amount is 46% lower than the $1.02 million spent on lobbying the federal government in the same period a...

In an effort to mould the legislation in its favor, health insurer UnitedHealth Group (UNH) has been reported to have spent $550,000 during the three months from July to September 2010. This amount is 46% lower than the $1.02 million spent on lobbying the federal government in the same period a...

Corcept Therapeutics Incorporated (NASDAQ: CORT) is up over 60% today after announcing positive top-line results from its Phase 3 study of CORLUX for the treatment of Cushing's Syndrome. The study evaluated the response of two patient groups to CORLUX treatment: one included patients who were...

Following Humana's (NYSE: HUM) acquisition of Concentra, management raised 2011 financial guidance by $0.10 to $5.45 to $5.65, Jefferies reports. “This is in line with the estimate we provided at the time of the deal announcement (note published Nov 23, 2010),” Jefferies writes. “However, we...

Humana Inc. (NYSE: HUM) today announced it has completed its previously announced acquisition of Concentra Inc., a privately held health care company based in Addison, Texas, for approximately $790 million in cash.